期刊文献+

心律失常发病机制研究进展 被引量:99

Advances in the study of arrhythmogenic mechanisms
暂未订购
导出
摘要 心律失常是心血管疾病常见的临床表现形式,尤其是室性心动过速、心室颤动等恶性心律失常,不但加重原有心脏疾病,还可诱发心源性猝死。目前抗心律失常药物的疗效并不十分理想,总有效率只有30%~60%。人们对心律失常作用机制的认识仍有限,因此,揭示心律失常发生的深层机制,寻找新的作用靶点是抗心律失常研究领域的重点、难点。近年人们发现心房特异性钾离子通道电流IKur、IKAch等参与了心房颤动,这使心房颤动治疗的研究向前推进一步。钙渗漏、缝隙连接蛋白及钙通道自身抗体在心律失常发生中发挥重要作用。这些发现为开发更有效的抗心律失常药物提供了理论基础。近年研究发现,一类调控基因的小分子RNA(microRNA,miRNA)在心血管疾病的发生、发展中起重要作用,特别是对心律失常及其引起的猝死起关键作用。miR-1、miR-133、miR-590等对心肌缺血、心肌梗死伴随的心律失常表现出明显调控作用。miRNA的生物学特性是同时对多个靶点具有调控作用,这使其具有成为理想抗心律失常靶点的潜力,为心律失常及猝死的防治带来希望。 Arrhythmia is a common complication of cardiovascular diseases and a risk factor for human health.Especially,ventricular tachycardia and ventricular fibrillation may not only exacerbate original heart diseases,but also cause cardiac sudden death which has been an important death reason in China.However,anti-arrhythmic drugs nowadays cannot effectively treat these arrhythmias,with an efficiency of only 30%-60% ,which indicates that our knowledge about arrhythmias is limited.Hence,to explore the potential mechanism,look for novel targets,and develop drugs with multiple-channel action are the focus of the research direction.Recent studies displayed that the atrial-specific potassium channels such as IKur and IKAch were involved in atrial fibrillation,which provided a prospective target for atrial fibrillation treatment.Calcium leak,gap junction protein and autoantibody against ICaL channel were shown to participate in arrhythmogenesis.These findings provided a theoretical basis for the development of more effective anti-arrhythmic drugs.Remarkably,as a kind of important RNA regulating gene expression,microRNA(miRNA) was shown to possess anti-arrhythmic activities which may prevent cardiac sudden death.miR-1,miR-133 and miR-590 regulated the arrhythmia in various types of animal models.Because of the multiple-gene regulation actions of miRNA,it has the potential to be developed as novel anti-arrhythmic target.
出处 《国际药学研究杂志》 CAS 2010年第2期81-88,共8页 Journal of International Pharmaceutical Research
基金 国家重大基础研究发展计划"973 计划"项目(2007CB512000) 国家自然科学基金重点项目(30430780) 国家自然科学基金面上项目(30672644) 国家自然科学基金中加国际合作项目(30711120580)
关键词 心律失常 离子通道 小分子RNA M3受体 心房颤动 缝隙连接蛋白 心肌梗死 AT1受体 溶血磷脂酰胆碱类 arrhythmia ion channels microRNA M3 receptor atrial fibrillation gap junction protein myocardial infarction AT1 receptor lysophosphatidylcholines
  • 相关文献

参考文献7

二级参考文献57

  • 1Snyders D J, Chaudhary A. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol 1996; 49: 949-55.
  • 2Spector PS, Cutran ME, Keating MT, Sanguinetti MC. Class HI antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K~ channel. Open-channel block by methanesulfonanilides. Circ Res 1996; 78: 499-503.
  • 3Wang Z, Yue L, White M, Pelletier G, Nattel S. Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation 1998; 98: 2422-8.
  • 4Yang BE Luo DL, Bao LH, Zhang YC, Wang HZ. Artemisinin blocks activating and slowly activating K+ current in guinea pig ventricular myocytes. Acta Pharmacol Sin 1998; 19: 269-72.
  • 5Yang BE Nattel S. Effects of RP58866 and 62719 on transmembrane K+ currents in mammalian ventricular myocytes.Biophysical 1997; 72:405.
  • 6Andersen HR, Wiggers HS, Knudsen L, Simon,sen I, Thomsen PEB, Christiansen N. Dofetilide reduces the incidence of ventricular fibrillation during acute myocardial ischemia. A randomized study in pigs. Cardiovasc Res 1994; 28: 1635-40.
  • 7Jurkiewicz NK, Wang J, Fermini B, Sanguinetti MC, Salata JJ. Mechanism of action potential prolongation by RP58866 and its active enantiomer, terikalant: block of the rapidly activating delayed rectifier K+ current, Ikr+ Circulation 1996;94: 2938-46.
  • 8Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995; 81: 299-307.
  • 9Busch AE, Eigenberger B, Jurkiewicz NK, Salata JJ, Pica A,Suessbricch H, et al. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action. Br J Pharmacol 1998; 123: 23-30.
  • 10Kiehn J, Laceda AE, Wible B, Brown AM. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide. Circulation 1996; 4: 2572-9.

共引文献1556

同被引文献1294

引证文献99

二级引证文献712

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部